ETON Exercise Disclosure
Maier Paul V · SEC Form 4 · Filed Aug 28, 2026
Exercise
Calculated transaction value
$0
Maier Paul V Director
ETON
Eton Pharmaceutcials
ETON
Transaction date
Aug 28, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed same day
ETON daily price context
Close on/before transaction
$59.78
Aug 28, 2026
Close before public filing
$62.67
Aug 27, 2026
Return since public filing
-11.74%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option on Common Stock
- Quantity / price
- 50,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-029196
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$3.14M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 28, 2026 | $7.91K |
| Eton Pharmaceuticals, Inc. ETON Current | Exercise | Aug 28, 2026 | $0 |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 28, 2026 | $189K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 28, 2026 | $2.13M |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 28, 2026 | $811.93K |